Recent Advances in Lipid Biomarkers Detection

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Point-of-Care Diagnostics and Devices".

Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 318

Special Issue Editor

Polymer Electronics Lab, Department of Bioelectronics and Biosensors, Alagappa University, Karaikudi 630003, Tamil Nadu, India
Interests: conducting polymers; natural polymers; metal oxide nanostructures; electrochemical sensors; metal organic frameworks

Special Issue Information

Dear Colleagues,

Many lifestyles have an impact on vital metabolic processes, which leads to illnesses, it can lead to interrelated problems, specifically, cardiovascular disease (CVD), which maintains that cholesterol is causal in the development of atherosclerotic cardiovascular disease (ASCVD) and that lowering cholesterol is associated with lower cardiovascular event rates. The impacts of metabolic diseases have received a lot of attention globally throughout the COVID-19 period. Thus, this review summarises studies on metabolic illnesses, including cardiovascular and diabetes mellitus. Drug research into diseases of lipid metabolism has also been taken into consideration. In this overview, lipids, metabolism, lipid metabolism problems, and medications used to treat them are examined.

Lipid biosensors are fluorescent protein fusions that can be used to monitor lipids in living cells. We highlight new probes and offer a list of the most recent, trustworthy, and extensively used biosensors (circa 2018–2021). We particularly concentrate on developments in phosphatidylinositol, phosphatidic acid, and PI 3-kinase lipid product biosensors. In order to measure the level of lipids (TG and TC) and lipoproteins (LDL and HDL) for the management of CVD at the point-of-care (POC), a range of quick, easy, and portable nanomaterial-based biosensors have been created.

Dr. Jeyaraj Wilson
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop